Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance.
Kaliszczak M, Patel H, Kroll SH, Carroll L, Smith G, Delaney S, Heathcote DA, Bondke A, Fuchter MJ, Coombes RC, Barrett AG, Ali S, Aboagye EO.
Kaliszczak M, et al. Among authors: delaney s.
Br J Cancer. 2013 Oct 29;109(9):2356-67. doi: 10.1038/bjc.2013.584. Epub 2013 Sep 26.
Br J Cancer. 2013.
PMID: 24071597
Free PMC article.